Endocrinology Editors and Editorial Board

Editor-in-Chief

Teresa K. Woodruff, PhD
Northwestern University
Chicago, Illinois, USA
Dr. Woodruff is the dean and associate provost for graduate education in the Graduate School at Northwestern University. She is also the Thomas J. Watkins Professor of Obstetrics & Gynecology, the vice chair for research, and the chief of the Division of Reproductive Science in Medicine in the Department of Obstetrics and Gynecology at the Feinberg School of Medicine. Dr. Woodruff is professor of molecular biosciences in the Weinberg College of Arts and Sciences and professor of biomedical engineering in the McCormick School of Engineering. She is the director of the Center for Reproductive Science, founder and director of the Women’s Health Research Institute, and director of the Oncofertility Consortium. Dr. Woodruff is an internationally recognized expert in ovarian biology and, in 2006, coined the term “oncofertility” to describe the merging of two fields: oncology and fertility. She now heads the Oncofertility Consortium, an interdisciplinary team of biomedical and social scientist experts from across the country. She has been active in education not only at the professional level but also with high school students. To this end, she founded and directs the Oncofertility Saturday Academy, one of several high school outreach programs that engages girls in basic and medical sciences. Dr. Woodruff was awarded the Presidential Award for Excellence in Science Mentoring in an Oval Office ceremony by President Obama in 2011. Widely recognized for her work, she holds 10 U.S. patents, and in 2013 she was named to Time magazine’s “Most Influential Persons” list. Some of Dr. Woodruff’s recent awards and honors include a Guggenheim Fellowship (2017), the Society for Endocrinology Transatlantic Medal (2017), and a Leadership Award from the Endocrine Society (2017). She has two honorary degrees, including one from the University of Birmingham College of Medical and Dental Sciences in the United Kingdom (2016). She is an elected fellow of the American Institute of Medical and Biological Engineering and the American Association for the Advancement of Science. Dr. Woodruff is past-president of the Endocrine Society and championed the new NIH policy that mandates the use of females in fundamental research. She is civically active and is an elected member of The Economic Club of Chicago and on the school board of the Chicago-based Young Women’s Leadership Charter School.

Associate Editors

Zane B. Andrews, PhD
Monash University
Clayton, Australia
Dr. Andrews is a National Health and Medical Research Council of Australia research fellow and an associate professor at the Monash Biomedicine Discovery Institute and Department of Physiology at Monash University in Melbourne, Australia. His research interests include neuroendocrinology, obesity and metabolism, and diabetes. His current research focuses on understanding neuroendocrine control of metabolism, mood, and motivation, with a particular attention to the neuroendocrine actions of ghrelin and ghrelin-target cells in the brain.

Richard J. Auchus, MD, PhD
University of Michigan
Ann Arbor, Michigan, USA
Dr. Auchus is a professor of pharmacology and internal medicine in the Division of Metabolism, Endocrinology and Diabetes at the University of Michigan and director of the Endocrinology Fellowship Program. His research program ranges from basic chemical principles of steroid biosynthetic enzymes and steroid mass spectrometry to clinical and translational investigation in disorders of the pituitary, adrenal, ovaries and testes that cause hypertension, infertility and obesity. His clinical interests also focus on pituitary, adrenal and reproductive diseases that involve disorders of steroid production, and he is particularly interested in the care of adults with genetic disorders of steroid biosynthesis and action.

Daniel J. Bernard, PhD
McGill University
Montréal, Québec, Canada
Dr. Bernard is a professor of pharmacology and therapeutics, anatomy and cell biology, physiology, and obstetrics and gynecology at McGill University in Montréal, Québec, Canada. He is the director of the McGill Centre for Research in Reproduction and Development and is a member of the Integrated Program in Neuroscience. The Bernard lab investigates the neuroendocrine control of the reproductive and thyroid axes. The lab is particularly interested in mechanisms of TGFβ superfamily and GnRH regulation of gonadotropin synthesis, as well as mechanisms underlying immunoglobulin superfamily member 1 (IGSF1) deficiency syndrome.

Patricia L. Brubaker, PhD
University of Toronto
Toronto, Ontario, Canada
Dr. Brubaker is professor and Canada Research Chair in the departments of physiology and medicine at the University of Toronto. Her research interests include gut hormone secretion and biological activities, with a focus on the incretin and satiety factor glucagon-like peptide-1 and the intestinal growth factor glucagon-like peptide-2.

Christin Carter-Su, PhD
University of Michigan
Ann Arbor, Michigan, USA
Dr. Carter-Su is Henry Sewall Collegiate Professor of Physiology and Anita H. Payne Distinguished University Professor of Physiology at the University of Michigan Medical School. She is also professor of internal medicine in the Division of Metabolism, Endocrinology and Diabetes and associate director of the Michigan Diabetes Research Center. Her research focuses on the signal transduction pathways and cellular responses initiated by receptor tyrosine kinases and cytokine family receptors that activate JAK kinases, with special attention to the receptors for growth hormone, prolactin, and leptin. Current work is focused on the mechanism of action, at the whole animal, cellular and molecular levels, of adaptor proteins that regulate energy expenditure, including isoform-specific responses.

Debabrata Chakravarti, PhD
Northwestern University
Chicago, Illinois, USA
Dr. Debabrata (Debu) Chakravarti is professor of obstetrics and gynecology and pharmacology at Northwestern University Feinberg School of Medicine. He is also the associate director of the Division of Reproductive Sciences in Medicine and the co-leader of the Cancer Epigenetics and Nuclear Dynamics Program of the Robert H. Lurie Comprehensive Cancer Center. His current research focuses on understanding the basic mechanisms of hormonal, transcriptional, and epigenomic regulation of uterine biology and prostate tumorigenesis, with an ultimate goal of translating these discoveries into potential therapeutics and a better understanding of reproductive pathophysiology.

Frédéric Flamant, PhD
École Normale Supérieure de Lyon
Lyon, France
Dr. Flamant is the deputy director of the Functional Genomics Institute, a laboratory of École Normale Supérieure de Lyon, and works as research director for Institut National de la Recherche Agronomique. For the last 10 years, Dr. Flamant’s work, based on mouse genetics, has been dedicated to the understanding of the neurodevelopmental function of thyroid hormone. He also participates in networks dedicated to endocrine disruption, with a focus on thyroid hormone disruption.

Douglas Forrest, PhD
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Bethesda, Maryland, USA
Dr. Forrest is a senior investigator at the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. His research interests focus on thyroid hormone, thyroid hormone metabolism, and the developmental and transcriptional roles of the nuclear thyroid hormone receptors. He also investigates neurodevelopmental functions of thyroid hormone receptors and orphan nuclear receptors.

Dana Gaddy, PhD
Texas A&M University
College Station, Texas, USA
Dr. Gaddy is a tenured professor in the Department of Veterinary Integrative Biosciences at Texas A&M University, College of Veterinary Medicine and Biological Sciences. Her long-standing research interests have addressed the signaling of activins and inhibins in bone, the regulation of the hypothalamic-pituitary-gonadal-skeletal axis across the menopause transition, and the effects of aging and disuse on bone metabolism, as well as the skeletal metabolism of fracture repair, bone infection, and Down syndrome. Her current work has incorporated the use and development of large animal models of rare bone diseases with an emphasis on hypophosphatasia.

Ruth A. Keri, PhD
Case Western Reserve University
Cleveland, Ohio, USA
Dr. Keri is a professor of pharmacology, genetics, and genome sciences and of oncology in the Division of General Medical Sciences at Case Western Reserve University. She is also the associate director for basic research in the Case Comprehensive Cancer Center. Dr. Keri’s research program focuses on identifying transcriptional and signaling mechanisms that control breast development, cancer initiation, and progression, with the goal of discovering new therapeutic approaches to the treatment of aggressive breast cancers. Her work integrates pharmacological approaches, cell biology, genomics, and mouse models. Dr. Keri also has a strong interest in endocrine disruptors, particularly those that impact normal morphogenesis and cancer risk.

Najiba Lahlou, MD, PhD
Paris Descartes University
Paris, France
Dr. Lahlou is a professor of hormonology at the Paris Descartes University and head of the Endocrine Department at BPR Clinical Laboratories. She manages a postgraduate degree course in fundamental and clinical hormonology. Her research activities focus on the biology of reproduction. She has a special interest in the physiology and pathology of gonadal peptide production, mainly in pediatrics, from birth to puberty. Concurrently she supervises the development of mass spectrometry for steroid measurement in clinical investigations, and promotes the use of steroid profiling for rapid diagnosis and characterization of genetic disorders and neoplastic diseases. She leads the mass spectrometry working group of the French Endocrine Society.

Ellis R. Levin, MD
University of California, Irvine
Long Beach, California, USA
Dr. Levin is Professor Above Scale and vice chairman in medicine, as well as chief of endocrinology at the University of California, Irvine, and Tibor Rubin Veterans Administration Medical Center. His basic science research focuses on estrogen receptors outside the nucleus (cell membrane and mitochondria) and their impact for organ development and modulation of cardiovascular diseases, breast cancer, and adipogenesis. His clinical interests span adults who manifest various endocrine disorders.

David D. Moore, PhD
Baylor College of Medicine
Houston, Texas, USA
Dr. Moore is a professor in the Department of Molecular and Cellular Biology at Baylor College of Medicine. His research program explores the diverse roles of the members of the nuclear hormone receptor superfamily, particularly in the liver. These receptors regulate basic metabolic pathways and other aspects of liver homeostasis, such as bile acid production. They are also linked to dysregulation of metabolic and growth pathways in diseases including diabetes and cancer.

Editorial Board

Publisher
Richard T. O’Grady, PhD

Executive Editor
Timothy M. Beardsley, DPhil

Acquisitions Editor
Caitlin R. Ondracek, PhD